| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8743763 | Transplant Immunology | 2018 | 8 Pages |
Abstract
Whereas everolimus might be advantageous as maintenance immunosuppressive agent, this data does not support an important role for everolimus in the immunosuppressive induction phase following lung transplantation.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
J. Salman, K. Jansson, Th. Siemeni, W. Sommer, A.-K. Knoefel, L. Ahrens, T. Nakagiri, F. Ius, I. Tudorache, B. Kruse, S. Thissen, D. Jonigk, M. Strüber, A. Haverich, G. Warnecke, M. Avsar,